143 related articles for article (PubMed ID: 21871825)
1. A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload.
Bardou-Jacquet E; Island ML; Jouanolle AM; Détivaud L; Fatih N; Ropert M; Brissot E; Mosser A; Maisonneuve H; Brissot P; Loréal O
Blood Cells Mol Dis; 2011 Dec; 47(4):243-8. PubMed ID: 21871825
[TBL] [Abstract][Full Text] [Related]
2. A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload.
Lam-Yuk-Tseung S; Camaschella C; Iolascon A; Gros P
Blood Cells Mol Dis; 2006; 36(3):347-54. PubMed ID: 16584902
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of the E399D DMT1/NRAMP2/SLC11A2 protein produced by an exon 12 mutation in a patient with microcytic anemia and iron overload.
Lam-Yuk-Tseung S; Mathieu M; Gros P
Blood Cells Mol Dis; 2005; 35(2):212-6. PubMed ID: 16023393
[TBL] [Abstract][Full Text] [Related]
4. Not all DMT1 mutations lead to iron overload.
Blanco E; Kannengiesser C; Grandchamp B; Tasso M; Beaumont C
Blood Cells Mol Dis; 2009; 43(2):199-201. PubMed ID: 19553145
[TBL] [Abstract][Full Text] [Related]
5. The homozygous mutation G75R in the human SLC11A2 gene leads to microcytic anaemia and iron overload.
Barrios M; Moreno-Carralero MI; Cuadrado-Grande N; Baro M; Vivanco JL; Morán-Jiménez MJ
Br J Haematol; 2012 May; 157(4):514-6. PubMed ID: 22313374
[No Abstract] [Full Text] [Related]
6. Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes.
Lam-Yuk-Tseung S; Touret N; Grinstein S; Gros P
Biochemistry; 2005 Sep; 44(36):12149-59. PubMed ID: 16142913
[TBL] [Abstract][Full Text] [Related]
7. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.
Beaumont C; Delaunay J; Hetet G; Grandchamp B; de Montalembert M; Tchernia G
Blood; 2006 May; 107(10):4168-70. PubMed ID: 16439678
[TBL] [Abstract][Full Text] [Related]
8. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.
Mims MP; Guan Y; Pospisilova D; Priwitzerova M; Indrak K; Ponka P; Divoky V; Prchal JT
Blood; 2005 Feb; 105(3):1337-42. PubMed ID: 15459009
[TBL] [Abstract][Full Text] [Related]
9. New Cases of Hypochromic Microcytic Anemia Due to Mutations in the
Romero-Cortadellas L; Hernández G; Ferrer-Cortès X; Zalba-Jadraque L; Fuster JL; Bermúdez-Cortés M; Galera-Miñarro AM; Pérez-Montero S; Tornador C; Sánchez M
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457224
[TBL] [Abstract][Full Text] [Related]
10. Divalent metal transporter 1.
Mims MP; Prchal JT
Hematology; 2005 Aug; 10(4):339-45. PubMed ID: 16085548
[TBL] [Abstract][Full Text] [Related]
11. DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis.
Kelleher T; Ryan E; Barrett S; O'Keane C; Crowe J
Blood Cells Mol Dis; 2004; 33(1):35-9. PubMed ID: 15223008
[TBL] [Abstract][Full Text] [Related]
12. Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2).
Lam-Yuk-Tseung S; Gros P
Biochemistry; 2006 Feb; 45(7):2294-301. PubMed ID: 16475818
[TBL] [Abstract][Full Text] [Related]
13. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function.
Hubert N; Hentze MW
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12345-50. PubMed ID: 12209011
[TBL] [Abstract][Full Text] [Related]
14. Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis.
Stuart KA; Anderson GJ; Frazer DM; Murphy TL; Powell LW; Fletcher LM; Crawford DH
Hepatology; 2004 Feb; 39(2):492-9. PubMed ID: 14768003
[TBL] [Abstract][Full Text] [Related]
15. H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics.
Shawki A; Knight PB; Maliken BD; Niespodzany EJ; Mackenzie B
Curr Top Membr; 2012; 70():169-214. PubMed ID: 23177986
[TBL] [Abstract][Full Text] [Related]
16. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
17. Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake.
Priwitzerova M; Nie G; Sheftel AD; Pospisilova D; Divoky V; Ponka P
Blood; 2005 Dec; 106(12):3985-7. PubMed ID: 16091455
[TBL] [Abstract][Full Text] [Related]
18. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
19. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
20. Expression of divalent metal transporter 1 (DMT1) isoforms in first trimester human placenta and embryonic tissues.
Chong WS; Kwan PC; Chan LY; Chiu PY; Cheung TK; Lau TK
Hum Reprod; 2005 Dec; 20(12):3532-8. PubMed ID: 16123094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
